Potential Therapeutic Targets and Promising Agents for Combating NAFLD

Nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), is a growing cause of liver cirrhosis and liver cancer worldwide because of the global increases in obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus. Contrary to the advancements in therapies fo...

全面介紹

書目詳細資料

Principais autores:	Atsushi Umemura, Seita Kataoka, Keiichiro Okuda, Yuya Seko, Kanji Yamaguchi, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2022-04-01
叢編:	Biomedicines
主題:	NAFLD NASH HCC honokiol HSC
在線閱讀:	https://www.mdpi.com/2227-9059/10/4/901
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!